Consistent with reported effects of DOT1L or DHODH (dihydroorotate dehydrogenase) [44], these findings indicate that MI treatment also overcomes differentiation blockage in AML cells with MLL1-r [17, 44]. This evidence concerns the gene KMT2A and acute myeloid leukemia.